当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › Health and Quality of Life Outcomes杂志
Health and Quality of Life Outcomes
基本信息
期刊名称 Health and Quality of Life Outcomes
HEALTH QUAL LIFE OUT
期刊ISSN 1477-7525
期刊官方网站 http://hqlo.biomedcentral.com/
是否OA
出版商 BioMed Central Ltd.
出版周期 Irregular
始发年份 2003
年文章数 236
最新影响因子 3.6(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学4区 HEALTH CARE SCIENCES & SERVICES 卫生保健与服务3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 2.66 1.083 1.313
Medicine
Public Health, Environmental and Occupational Health
86 / 489 82%
补充信息
自引率 6.90%
H-index 85
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
Speed
120 days to first decision for reviewed manuscripts only
102 days to first decision for all manuscripts
237 days from submission to acceptance
15 days from acceptance to publication
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1477-7525%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/hqlo/default.aspx
收稿范围

Health and Quality of Life Outcomes considers original manuscripts on the Health-Related Quality of Life (HRQOL) assessment for evaluation of medical and psychosocial interventions. It also considers approaches and studies on psychometric properties of HRQOL and patient reported outcome measures, including cultural validation of instruments if they provide information about the impact of interventions. The journal publishes study protocols and reviews summarising the present state of knowledge concerning a particular aspect of HRQOL and patient reported outcome measures. Reviews should generally follow systematic review methodology. Comments on articles and letters to the editor are welcome.

收录体裁
Research article
Commentary
Letter to the Editor
Review
Short report
Study protocol
投稿指南 https://hqlo.biomedcentral.com/submission-guidelines
投稿模板 https://hqlo.biomedcentral.com/submission-guidelines/preparing-your-manuscript
参考文献格式 https://hqlo.biomedcentral.com/submission-guidelines/preparing-your-manuscript
编辑信息

Editor-in-Chief
Prof Holger Schunemann, McMaster University, Canada

Deputy Editor
Dr Feng Xie, McMaster University, Canada

Associate Editors
Dr Eduardo Bernabé, King's College London, UK
Dr Claudio Bilotta, Presidio Territoriale Poliambulatori, ASST Nord Milano, Milan, Italy
Dr Jan Brozek, McMaster University, Canada
Dr Yaolong Chen, Lanzhou University, China
Dr Pablo Alonso Coello, IIB Sant Pau, Spain
Dr Fabio Efficace, GIMEMA, University of Rome, Italy
Prof Eduardo Fernández, University of Chile, Chile
Dr Sai-fu Fung, City University of Hong Kong, China
Dr Joel Gagnier, University of Michigan, USA
Dr Wei Gao, King's College London, UK
Dr Man Hung, Roseman University of Health Sciences, USA
Dr Tatsunori Ikemoto, Aichi Medical University, Japan
Dr Pascal Jean-Pierre, Florida State University College of Medicine, USA
Prof Ali Montazeri, Iranian Institute for Health Sciences Research, ACECR, Iran
Dr Mark Oremus, University of Waterloo, Canada
Prof Jeffery Sloan, Mayo clinic, USA
Dr Georgios Tsakos, University College London, UK
Prof Abebaw Yohannes, Manchester Metropolitan University, UK
Dr Yuan Zhang, McMaster University, Canada

Statistical Advisor
Dr Francesco Cottone, Italian Group for Adult Hematologic Diseases (GIMEMA), Italy

Editorial Board
Dr Giovanni Apolone, Istituto di Ricerche Farmacologiche Mario Negri, Italy
Dr Xavier Badia, IMS health, Spain
Prof Enzo Ballatori, University of L'Aquila, Italy
Prof Clare Bradley, Royal Holloway University of London, UK
Dr David Brennan, The University of Adelaide, Australia
Dr Anne Brédart, Institut Curie, France
Dr Cinzia Brunelli, Fondazione IRCCS INT-MILANO, Italy
Dr Augusto Caraceni, National Cancer Institute, Italy
Dr Mauro Carone, Fondazione Salvatore Maugeri, Italy
Prof Charles S Carver, University of Miami, USA
Dr Paolo G Casali, National Institute of Cancer, Italy
Dr Barrie Cassileth, Memorial Sloan-Kettering Cancer Center, USA
Dr David Cella, Evanston Northwestern Healthcare, USA
Dr Massimo Costantini, National Cancer Institute, Italy
Dr Frank de Charro, Eramus University Rotterdam, Netherlands
Dr Franco De Conno, National Cancer Institute, Italy
Dr Sonya Emerenco, Evanston Northwestern Healthcare, USA
Dr Calliope CF Farsides, Centre of Medical Law and Ethics, UK
Prof James Fitzgerald, University of Michigan, USA
Ms Daniela Goursand, UFMG, Brazil
Prof Luigi Grassi, University of Ferrara, Italy
Dr Thomas Greenfield, Public Health Institute, USA
Dr Digant Gupta, Cancer Treatment Centers of America, USA
Prof Irene J Higginson, King's College London, UK
Dr William Holmes, University of Pennsylvania School of Medicine, USA
Prof Michael Hyland, University of Plymouth, UK
Dr Paul B Jacobsen, Moffitt Cancer Center, USA
Prof Robert M Kaplan, University of California, USA
Dr Anne Kouvonen, Queen's University Belfast, UK
Dr Mark S Litwin, University of California Los Angeles, USA
Dr Ruth McCorkle, Yale University, USA
Prof Susan C McMillan, Health University of South Florida, USA
Prof Linda Moody, University of South Florida, USA
Dr Paola Mosconi, Istituto di Ricerche Farmacologiche Mario Negri, Italy
Dr Brian Ott, Brown Medical School, USA
Dr Eugenio Paci, Center for the Study and Prevention of Cancer, Italy
Dr Franca Porciani, Rizzoli Corriere della Sera - Milano, Italy
Dr Giuseppe Recchia, GSK, Italy
Dr Daniel Reissmann, University Medical Center Hamburg-Eppendorf, Germany
Dr Fausto Roila, Medical Oncology, S. Maria Hospital, Terni, Italy
Dr Amedeo Santosuosso, Ministry of Justice, Italy
Prof Surya Shah, University of Tennessee, USA
Dr John Spertus, University of Missouri, USA
Dr Michele Tomamichel, Psychiatric and Medical Psychology Service, Switzerland
Dr Franco Toscani, Istituto di Ricerca in Medicina Palliativa, Italy
Prof James Varni, Children's Hospital and Health Center, USA
Prof Stephen J Walters, University of Sheffield, UK
Dr Michael Weitzner, Moffitt Cancer Center, USA
Prof Jerome Yesavage, Stanford University, USA


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug